Skip to content

Cerus CERS Investment Proceeds

Investment Proceeds at other companies

CorMedix logo
CorMedixCRMD
$3.69M-62.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$145.1M-15.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$156.69M+38.4%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's investment proceeds?
Cerus (CERS) reported investment proceeds of $18.5M in Q1 2026.
How has Cerus's investment proceeds changed year-over-year?
Cerus's investment proceeds increased by 168.7% year-over-year, from $6.89M to $18.5M.
What is the long-term trend for Cerus's investment proceeds?
Over 4 years (2021 to 2025), Cerus's investment proceeds has grown at a -11.5% compound annual growth rate (CAGR), from $65.66M to $40.34M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.